Antimitotic Agents: all 5,052 studies that test it

Page 10 of 51. Open to participants first (616), then studies with results posted, then the rest; newest registration first within each.

• Cabazitaxel Versus the Switch to Alternative AR-targeted Agent (Enzalutamide or Abiraterone) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Patients Previously Treated With Docetaxel and Who Rapidly Failed a Prior AR-targeted AgentCompletedNCT02485691Phase 4Results posted
• Study to Evaluate the Efficacy and Safety of Eribulin Mesylate Administered Biweekly (Q2W) for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Metastatic Breast CancerCompletedNCT02481050Phase 2Results posted
• An Investigational Immuno-therapy Trial of Nivolumab, or Nivolumab Plus Ipilimumab, or Nivolumab Plus Platinum-doublet Chemotherapy, Compared to Platinum Doublet Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC)CompletedNCT02477826Phase 3Results posted
• Carboplatin Plus Docetaxel With Day 2 Pegylated G-CSF (Neulasta®) in Patients With Advanced Stage Ovarian CarcinomaTerminatedNCT02469116Phase 2Results posted
• Safety Study of Pertuzumab (in Combination With Trastuzumab and Docetaxel) in Indian Participants With Breast CancerCompletedNCT02445586Phase 4Results posted
• Dose Dense Paclitaxel With Pembrolizumab (MK-3475) in Platinum Resistant Ovarian CancerCompletedNCT02440425Phase 2Results posted
• The Pharmacokinetics and Safety of Olaparib Alone and With Paclitaxel in Chinese Patients With Advanced Solid Tumour.CompletedNCT02430311Phase 1Results posted
• Nab-paclitaxel and Gemcitabine Hydrochloride Followed by Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by SurgeryCompletedNCT02427841Phase 2Results posted
• Safety and Efficacy of Trastuzumab as Part of Breast Cancer Treatment RegimenCompletedNCT02419742Phase 4Results posted
• Neoadjuvant Study of Two Platinum Regimens in Triple Negative Breast CancerCompletedNCT02413320Phase 2Results posted
• A Safety, Tolerability, and Pharmacokinetics Study of MLN0128 as a Single Agent and in Combination With Paclitaxel in Adults With Advanced Nonhematologic MalignanciesCompletedNCT02412722Phase 1Results posted
• Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract CancerCompletedNCT02412670Phase 2Results posted
• Safety and Efficacy of Entospletinib With Vincristine and Dexamethasone in Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)TerminatedNCT02404220Phase 1/2Results posted
• AZD2014 and Weekly Paclitaxel in Squamous NSCLCTerminatedNCT02403895Phase 2Results posted
• Docetaxel With or Without TAK-117 (MLN1117) in Participants With Locally Advanced or Metastatic Non-small Cell Lung CancerTerminatedNCT02393209Phase 1/2Results posted
• Gemcitabine Hydrochloride, Cisplatin, and Nab-Paclitaxel in Treating Patients With Advanced or Metastatic Biliary CancersCompletedNCT02392637Phase 2Results posted
• A Study of Nab-Paclitaxel and Carboplatin Plus Necitumumab (LY3012211) in Participants With Stage IV Squamous NSCLCCompletedNCT02392507Phase 2Results posted
• Molecular Phenotyping in Predicting Response in Patients With Stage IB-III Esophageal Cancer Receiving Combination ChemotherapyTerminatedNCT02392377Phase 2Results posted
• A Study of CRLX101(NLG207) in Combination With Weekly Paclitaxel in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal CancerTerminatedNCT02389985Phase 1/2Results posted
• Phase 1/2a Dose-Escalation Study of CRLX301 in Patients With Advanced Solid TumorsTerminatedNCT02380677Phase 1/2Results posted
• Fasting on Newly Diagnosed Breast CancerTerminatedNCT02379585Phase 1/2Results posted
• Cabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Primary Resistant Patients to Abiraterone or EnzalutamideTerminatedNCT02379390Phase 2Results posted
• BYL719 and Nab-Paclitaxel in Locally Recurrent or Metastatic HER-2 Negative Breast CancerCompletedNCT02379247Phase 1/2Results posted
• A Study of Atezolizumab in Combination With Carboplatin + Paclitaxel or Carboplatin + Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower131]CompletedNCT02367794Phase 3Results posted
• Alisertib (MLN8237) in Combination With Weekly Paclitaxel in East Asian Patients With Advanced Solid TumorsTerminatedNCT02367352Phase 1Results posted
• Inflammation and Coronary Endothelial FunctionCompletedNCT02366091Phase 2Results posted
• Molecularly Tailored Therapy for Patients With Metastatic Cancer of the Esophagus and StomachTerminatedNCT02358863Not applicableResults posted
• Study of Mogamulizumab + Docetaxel in Subjects With Non-small Cell Lung CancerCompletedNCT02358473Phase 1Results posted
• Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgkin LymphomaCompletedNCT02348216Phase 1/2Results posted
• Phase III Study of Vinflunine Plus Methotrexate Versus Methotrexate Alone in Patients With Head and Neck CancerCompletedNCT02347332Phase 3Results posted
• A Phase 1b Study of PEGylated Recombinant Human Hyaluronidase (PEGPH20) Combined With Docetaxel in Subjects With Recurrent Previously Treated Locally Advanced or Metastatic NSCLCTerminatedNCT02346370Phase 1Results posted
• Neoadjuvant Hormonal Therapy Combined With ChemoimmunotherapyTerminatedNCT02345772Phase 1/2Results posted
• Phase Ib Study AZD1775 in Combination With Carboplatin and Paclitaxel in Adult Asian Patients With Solid TumoursCompletedNCT02341456Phase 1Results posted
• Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaTerminatedNCT02337478Phase 2Results posted
• LCI-LUN-ABR-001: Carbo With Nab-Paclitaxel in Patients With Advanced NSCL CancerCompletedNCT02328105Phase 2Results posted
• A Study MLN2480 in Combination With MLN0128 or Alisertib, or Paclitaxel, or Cetuximab, or Irinotecan in Adult Participants With Advanced Nonhematologic MalignanciesCompletedNCT02327169Phase 1Results posted
• Study of Gemcitabine/Taxotere/Xeloda (GTX) in Combination With Cisplatin and Irinotecan in Subjects With Metastatic Pancreatic CancerCompletedNCT02324543Phase 1/2Results posted
• A Study of Cobimetinib Plus Paclitaxel, Cobimetinib Plus Atezolizumab Plus Paclitaxel, or Cobimetinib Plus Atezolizumab Plus Nab-Paclitaxel as Initial Treatment for Participants With Triple-Negative Breast Cancer That Has SpreadTerminatedNCT02322814Phase 2Results posted
• Study of Nab-Paclitaxel and Ramucirumab as Second-line Treatment for Patients With Metastatic Gastroesophageal CancerCompletedNCT02317991Phase 2Results posted
• Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast CancerActive, not recruitingNCT02315196Phase 2Results posted
• Avatar-Directed Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube CancerCompletedNCT02312245Phase 2Results posted
• Phase II Study of Abraxane and Gemicitabine in Patients With Advanced Adenocarcinoma Non-Small Cell Lung Cancer Progressing After First-Line Platinum-Based ChemotherapyCompletedNCT02303977Phase 2Results posted
• Phase 2 Nab® -Paclitaxel (Abraxane®) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAPC)CompletedNCT02301143Phase 2Results posted
• Nintedanib Plus Docetaxel in Japanese Patients With Adenocarcinoma Subtype Non-small Cell Lung Cancer After Failure of First Line ChemotherapyCompletedNCT02300298Phase 1Results posted
• Locally Advanced Breast Cancer: Individualized Treatment Based On Tumor Molecular CharacteristicsTerminatedNCT02297230Phase 1/2Results posted
• Study of Gemcitabine, Abraxane® Plus Placebo Versus Gemcitabine, Abraxane® Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With 1st-Line Metastatic Pancreatic Ductal AdenocarcinomaCompletedNCT02289898Phase 2Results posted
• Phase II Safety and Tolerability Trial With Nab-Paclitaxel Plus Carboplatin Followed by Nab-Paclitaxel for First Line Treatment of NSCLC Subjects With ECOG PS 2CompletedNCT02289456Phase 2Results posted
• Study of Concurrent Paclitaxel and Radiation: Correlation of Tumor Profiles With Pathologic ResponseCompletedNCT02280252Phase 2Results posted
• Nab-paclitaxel and Carboplatin Followed by Response-Based Local Therapy in Treating Patients With Stage III or IV HPV-Related Oropharyngeal CancerCompletedNCT02258659Phase 2Results posted
• Vincristine Sulfate Liposome Injection (Marqibo®), Bendamustine and Rituximab-Phase I Trial in Indolent B-cell LymphomaCompletedNCT02257242Phase 1Results posted
• Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in Treatment of Metastatic Castration Resistant Prostate CancerCompletedNCT02218606Phase 2Results posted
• Study Assessing the Feasibility of a Surgery and Chemotherapy-Only in Children With Wnt Positive MedulloblastomaTerminatedNCT02212574Early Phase 1Results posted
• Evaluation of Votrient in AngiosarcomaTerminatedNCT02212015Phase 2Results posted
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine Hydrochloride With or Without WEE1 Inhibitor AZD1775 in Treating Patients With Previously Untreated Pancreatic Cancer That Is Metastatic or Cannot Be Removed by SurgeryCompletedNCT02194829Phase 1/2Results posted
• Phase II Trial of Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With CholangiocarcinomaCompletedNCT02181634Phase 2Results posted
• Immune-Modulated Study of Selected Small Molecules (Gefitinib, AZD9291, or Selumetinib + Docetaxel) or a 1st Immune-Mediated Therapy (IMT; Tremelimumab) With a Sequential Switch to a 2nd IMT (MEDI4736) in Patients With Locally Advanced or Metastatic Non-Small-Cell Lung CancerCompletedNCT02179671Phase 2Results posted
• Gemcitabine, Nab-paclitaxel and KPT-330 in Advanced Pancreatic CancerCompletedNCT02178436Phase 1/2Results posted
• Gemcitabine Hydrochloride and Eribulin Mesylate in Treating Patients With Bladder Cancer That is Advanced or Cannot Be Removed by SurgeryCompletedNCT02178241Phase 2Results posted
• S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder CancerCompletedNCT02177695Phase 2Results posted
• Colchicine to Prevent Post-Pericardiotomy Syndrome and Atrial FibrillationTerminatedNCT02177266Phase 3Results posted
• This is a Phase 1 Study of Eribulin Mesylate in Pediatric Participants With Recurrent or Refractory Solid Tumors (Excluding [Central Nervous System] CNS), Including LymphomasCompletedNCT02171260Phase 1Results posted
• Nab-Paclitaxel and Bevacizumab or Ipilimumab as First-Line Therapy in Treating Patients With Stage IV Melanoma That Cannot Be Removed by SurgeryCompletedNCT02158520Phase 2Results posted
• Dose-Dense Induction/Neoadjuvant Chemotherapy in Locally Advanced Non-Small Cell Lung CancerTerminatedNCT02157116Phase 2Results posted
• Effects of Colchicine in Non-Diabetic Adults With Metabolic SyndromeCompletedNCT02153983Phase 1/2Results posted
• Inolitazone Dihydrochloride and Paclitaxel in Treating Patients With Advanced Anaplastic Thyroid CancerCompletedNCT02152137Phase 2Results posted
• Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the ElderlyCompletedNCT02151149Phase 4Results posted
• Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic LeukemiaActive, not recruitingNCT02143414Phase 2Results posted
• Anti-platelet Effects of Colchicine in Healthy VolunteersCompletedNCT02140372Phase 4Results posted
• Clofarabine, Idarubicin, Cytarabine, Vincristine Sulfate, and Dexamethasone in Treating Patients With Newly Diagnosed or Relapsed Mixed Phenotype Acute LeukemiaCompletedNCT02135874Phase 2Results posted
• A Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated BiomarkersCompletedNCT02132468Phase 2Results posted
• Maximum Tolerated Dose, Safety and Efficacy of Docetaxel / Cisplatin + STI571TerminatedNCT02127372Phase 1/2Results posted
• Neoadjuvant Treatment of Triple Negative Breast Cancer Patients With Docetaxel and Carboplatin to Assess Anti-tumor ActivityTerminatedNCT02124902Phase 2Results posted
• Weekly Carboplatin, Paclitaxel and Cetuximab Treatment for Patients With Recurrent or Metastatic SCCHNCompletedNCT02124707Phase 2Results posted
• Eribulin Mesylate and Everolimus in Treating Patients With Triple-Negative Metastatic Breast CancerCompletedNCT02120469Phase 1Results posted
• Paclitaxel and Intraperitoneal Carboplatin Followed by Radiation Therapy in Treating Patients With Stage IIIC-IV Uterine CancerTerminatedNCT02112552Phase 2Results posted
• Quality of Life in Locally Advanced or Metastatic Pancreatic Cancer Treated With Gemcitabine and Nab-paclitaxelCompletedNCT02106884Phase 2Results posted
• Phase 2 Study With Abraxane (Nab®Paclitaxel) in Metastatic Colorectal CancerCompletedNCT02103062Phase 2Results posted
• Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic LeukemiaActive, not recruitingNCT02101853Phase 3Results posted
• Eribulin Mesylate in Treating Patients With Recurrent or Refractory OsteosarcomaCompletedNCT02097238Phase 2Results posted
• Study of IDO Inhibitor in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic CancerCompletedNCT02077881Phase 1/2Results posted
• Treatment With Nab-paclitaxel in Cutaneous SCCTerminatedNCT02076243Phase 2Results posted
• Phase I/II Trial of the Combination of Lenalidomide (Revlimid) and Nab-paclitaxel (Abraxane) in the Treatment of Relapsed/Refractory Multiple MyelomaTerminatedNCT02075021Phase 1/2Results posted
• PET-Adjusted Intensity Modulated Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II-IV Non-small Cell Lung CancerCompletedNCT02073968Phase 2Results posted
• Neoadjuvant TDM1 With Lapatinib and Abraxane Compared With Trastuzumab Plus Pertuzumab With PaclitaxelCompletedNCT02073487Phase 2Results posted
• Monotherapy With Eribulin In Her2 Negative Metastatic Breast Cancer as a First Line TreatmentCompletedNCT02061085Phase 2Results posted
• A Study Evaluating the Safety, Efficacy and Pharmacokinetics of Venetoclax Combined With Chemotherapy in Participants With B-Cell Non-Hodgkin's Lymphoma (NHL) and DLBCLCompletedNCT02055820Phase 1/2Results posted
• A Study of Vinflunine Plus Gemcitabine Versus Paclitaxel Plus Gemcitabine in Patients With Advanced Breast CancerTerminatedNCT02054338Phase 3Results posted
• Phase I TH-302 Plus Gemcitabine Plus Nab-Paclitaxel in Pancreatic CancerTerminatedNCT02047500Phase 1Results posted
• Eribulin Mesylate or Paclitaxel as First- or Second-Line Therapy in Treating Patients With Recurrent Stage IIIC-IV Breast CancerSuspendedNCT02037529Phase 3Results posted
• 131I-MIBG Alone VS. 131I-MIBG With Vincristine and Irinotecan VS131I-MIBG With VorinostatCompletedNCT02035137Phase 2Results posted
• Nab-Paclitaxel to Paclitaxel in Advanced Urothelial Cancer Progressing on or After Platinum Containing Regimen.CompletedNCT02033993Phase 2Results posted
• Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung CancerCompletedNCT02027428Phase 3Results posted
• Study of LDE225 (Sonidegib) in Combination With Docetaxel in Triple Negative (TN) Advanced Breast Cancer (ABC) PatientsCompletedNCT02027376Phase 1Results posted
• Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed, Non-metastatic Desmoplastic MedulloblastomaCompletedNCT02017964Phase 2Results posted
• Safety and Efficacy Study of Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Metastatic Pancreatic CancerCompletedNCT02017015Phase 2Results posted
• A Study of Herceptin (Trastuzumab) in Combination Chemotherapy in Patients With Metastatic or Locally Advanced Breast CancerCompletedNCT02015676Phase 1/2Results posted
• A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Primary Breast CancerCompletedNCT02005549Phase 2Results posted
• Pilot Study to Evaluate Reparixin With Weekly Paclitaxel in Patients With HER 2 Negative Metastatic Breast Cancer (MBC)CompletedNCT02001974Phase 1Results posted
• Colchicine Or Naproxen Treatment for ACute gouTCompletedNCT01994226Phase 4Results posted
• Colchicine For Prevention of Perioperative Atrial Fibrillation in Patients Undergoing Thoracic Surgery Pilot StudyCompletedNCT01985425Phase 3Results posted

← Antimitotic Agents overview